title: Unique substrate recognition mechanism of the botulinum neurotoxin D light chain.
abstract: Botulinum neurotoxins are the most potent protein toxins in nature. Despite the potential to block neurotransmitter release at the neuromuscular junction and cause human botulism, they are widely used in protein therapies. Among the seven botulinum neurotoxin serotypes, mechanisms of substrate recognition and specificity are known to a certain extent in the A, B, E, and F light chains, but not in the D light chain (LC/D). In this study, we addressed the unique substrate recognition mechanism of LC/D and showed that this serotype underwent hydrophobic interactions with VAMP-2 at its V1 motif. The LC/D B3, B4, and B5 binding sites specifically recognize the hydrophobic residues in the V1 motif of VAMP-2. Interestingly, we identified a novel dual recognition mechanism employed by LC/D in recognition of VAMP-2 sites at both the active site and distal binding sites, in which one site of VAMP-2 was recognized by two independent, but functionally similar LC/D sites that were complementary to each other. The dual recognition strategy increases the tolerance of LC/D to mutations and renders it a good candidate for engineering to improve its therapeutic properties. In conclusion, in this study, we identified a unique multistep substrate recognition mechanism by LC/D and provide insights for LC/D engineering and antitoxin development.
authors: From the Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong, China.
authors: Jiubiao
authors: J
authors: Guo
authors: Sheng
authors: S
authors: Chen
mesh_terms: D020816:Amino Acid Motifs; D000992:Antitoxins / Q000737:chemistry; D001665:Binding Sites; D001905:Botulinum Toxins / Q000737:chemistry*; D002384:Catalysis; D002942:Circular Dichroism; D006801:Humans; D045726:Metalloproteases / Q000737:chemistry; D008958:Models, Molecular; D009474:Neurons / Q000378:metabolism; D010957:Plasmids / Q000378:metabolism; D011485:Protein Binding; D015202:Protein Engineering / Q000379:methods; D017434:Protein Structure, Tertiary; D050988:Vesicle-Associated Membrane Protein 2 / Q000737:chemistry*
chemical_list: D000992:Antitoxins; C494807:VAMP2 protein, human; D050988:Vesicle-Associated Membrane Protein 2; C096325:botulinum toxin type D; D045726:Metalloproteases; D001905:Botulinum Toxins
keywords: Bacterial Toxins; Enzyme Catalysis; Enzyme Kinetics; Metalloprotease; Neurotoxin
references: Mol Microbiol. 1994 Jul;13(1):1-8
references: 7527117
references: J Biol Chem. 2007 Aug 31;282(35):25540-7
references: 17609207
references: Biochemistry. 2012 May 8;51(18):3941-7
references: 22510015
references: Nature. 1994 Dec 1;372(6505):415-6
references: 7984234
references: Biochemistry. 2006 Mar 14;45(10):3255-62
references: 16519520
references: Am J Health Syst Pharm. 2006 Feb 1;63(3):225-32
references: 16434781
references: JAMA. 2001 Feb 28;285(8):1059-70
references: 11209178
references: Clin J Pain. 2002 Nov-Dec;18(6 Suppl):S191-7
references: 12569968
references: Nature. 2004 Dec 16;432(7019):925-9
references: 15592454
references: J Biol Chem. 2008 Jul 25;283(30):21145-52
references: 18511418
references: Q Rev Biophys. 2005 Feb;38(1):1-47
references: 16336742
references: J Biol Chem. 2008 Jul 25;283(30):21153-9
references: 18511417
references: J Biol Chem. 2007 Mar 30;282(13):9621-9627
references: 17244603
references: Ann N Y Acad Sci. 1994 Mar 9;710:65-75
references: 7786341
references: Presse Med. 2003 Mar 15;32(10):463-5
references: 12733311
references: N Engl J Med. 1991 Apr 25;324(17):1186-94
references: 2011163
references: Trends Neurosci. 2005 Aug;28(8):446-52
references: 15979165
references: Biochem J. 2011 Jan 15;433(2):277-84
references: 21029044
references: Toxicon. 1997 Sep;35(9):1373-412
references: 9403963
references: Dermatol Surg. 2004 Mar;30(3):452-5
references: 15008883
references: Trends Biochem Sci. 1993 Sep;18(9):324-7
references: 7901925
references: J Biol Chem. 2006 Apr 21;281(16):10906-11
references: 16478727